Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2009;54:399-404
Published online before print May 26, 2009, doi: 10.1161/HYPERTENSIONAHA.109.133041
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
54/2/399    most recent
HYPERTENSIONAHA.109.133041v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Kengne, A.-P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kengne, A.-P.
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Clinical Studies
Right arrow Epidemiology

(Hypertension. 2009;54:399.)
© 2009 American Heart Association, Inc.


Seventh International Workshop on Structure and Function of the Vascular System

Blood Pressure Variables and Cardiovascular Risk

New Findings From ADVANCE

Andre-Pascal Kengne; Sébastien Czernichow; Rachel Huxley; Diederick Grobbee; Mark Woodward; Bruce Neal; Sophia Zoungas; Mark Cooper; Paul Glasziou; Pavel Hamet; Stephen B. Harrap; Giuseppe Mancia; Neil Poulter; Bryan Williams; John Chalmers on behalf of the ADVANCE Collaborative Group

From the George Institute for International Health (A.-P.K., S.C., R.H., M.W., B.N., S.Z., J.C.), University of Sydney, Sydney, New South Wales, Australia; Department of Public Health (S.C.), Avicenne Hospital, University of Paris 13, Paris, France; Julius Centre for Health Sciences and Primary Care (D.G.), University Medical Centre Utrecht, Utrecht, The Netherlands; Mount Sinai School of Medicine (M.W.), New York, NY; Monash University (S.Z.), Melbourne, Victoria, Australia; Baker IDI Heart Research Institute (M.C.), Melbourne, Victoria, Australia; Centre for Evidence-Based Medicine (P.G.), Department of Primary Health Care, University of Oxford, Oxford, United Kingdom; Centre Hospitalier de l’Université de Montréal (P.H.), Université de Montréal, Montréal, Quebec, Canada; Department of Physiology (S.B.H.), University of Melbourne, Melbourne, Victoria, Australia; University of Milan-Biocca and San Gerardo Hospital (G.M.), Milan, Italy; Imperial College and St Mary’s Hospital (N.P.), London, United Kingdom; and the Department of Cardiovascular Sciences (B.W.), University of Leicester, Leicester, United Kingdom.

Correspondence to John Chalmers, ADVANCE Collaborative Group, The George Institute for International Health, PO Box M201, Missenden Road, Sydney NSW 2050, Australia. E-mail jchalmers{at}george.org.au

The relative importance of various blood pressure indices on cardiovascular risk in people with type 2 diabetes mellitus has not been established. This study compares the strengths of the associations between different baseline blood pressure variables (systolic blood pressure [SBP], diastolic blood pressure [DBP], pulse pressure [PP], and mean arterial pressure) and the 4.3-year risk of major cardiovascular events in the Action in Diabetes and Vascular Disease: Preterax and Diamicron-Modified Release Controlled Evaluation Study. Mean (SD) age for the 11 140 participants was 65.8 years (6.4 years). During follow-up, 1000 major cardiovascular events, 559 major coronary events, and 468 cardiovascular deaths were recorded. After adjustment for age, sex, and treatment allocation, the hazard ratios (95% CIs) associated with 1 increment in SD for the risk of major cardiovascular events were 1.17 (1.10 to 1.24) for SBP; 1.20 (1.13 to 1.28) for PP; 1.12 (1.05 to 1.19) for mean arterial pressure; and 1.04 (0.98 to 1.11) for DBP. The areas under the receiver operating characteristic curve were slightly higher for SBP and PP compared with mean arterial pressure and DBP for major cardiovascular and coronary events. Using achieved instead of baseline blood pressure values marginally improved the effect estimates for SBP, DBP, and mean arterial pressure, with no significant differences in the areas under the receiver operating characteristic curve between models with SBP and those with PP. In conclusion, SBP and PP are the 2 best and DBP is the least effective determinant of the risk of major cardiovascular outcomes in the relatively old patients with type 2 diabetes mellitus participating in the Action in Diabetes and Vascular Disease: Preterax and Diamicron-Modified Release Controlled Evaluation Study. However, SBP may be the simplest and most useful predictor across a wider range of age groups and populations.


Key Words: blood pressure variables • type 2 diabetes mellitus • cardiovascular disease • risk prediction • discrimination capability




This article has been cited by other articles:


Home page
HypertensionHome page
H. A. Struijker-Boudier, J. Blacher, B. I. Levy, and M. E. Safar
Introduction to the Seventh International Workshop on Structure and Function of the Vascular System
Hypertension, August 1, 2009; 54(2): 373 - 374.
[Full Text] [PDF]